BridgeBio Pharma Inc
XBER:2CL
BridgeBio Pharma Inc
XBER:2CL
Price:
0.057
EUR
Market Closed
Market Cap:
€8.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BridgeBio Pharma Inc
XBER:2CL
|
US |
|
CanAlaska Uranium Ltd
F:DH7
|
CA |
|
Maps SpA
MIL:MAPS
|
IT |
Wall St Price Targets
2CL Price Targets Summary
BridgeBio Pharma Inc
BridgeBio Pharma Inc
Wall Street analysts forecast 2CL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 2CL is 0.089 EUR with a low forecast of 0.068 EUR and a high forecast of 0.14 EUR.
Lowest Forecast
Price Target
0.068
EUR
20% Upside
Average Forecast
Price Target
0.089
EUR
57% Upside
Highest Forecast
Price Target
0.14
EUR
145% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2CL's stock price target?
Price Target
0.089
EUR
0.089
EUR
According to Wall Street analysts, the average 1-year price target for 2CL is 0.089 EUR with a low forecast of 0.068 EUR and a high forecast of 0.14 EUR.
What is the Revenue forecast for BridgeBio Pharma Inc?
Projected CAGR
37%
37%
The compound annual growth rate for Revenue over the next 8 years is 37%.
